Viewing Study NCT00654602


Ignite Creation Date: 2025-12-25 @ 3:55 AM
Ignite Modification Date: 2026-02-25 @ 8:30 PM
Study NCT ID: NCT00654602
Status: COMPLETED
Last Update Posted: 2009-05-28
First Post: 2008-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module